Allianz Asset Management Portfolio holdings
AUM
$74.9B
1-Year Return
18.5%
This Quarter Return
+12.84%
1 Year Return
+18.5%
3 Year Return
+81.04%
5 Year Return
+172.66%
10 Year Return
+376.49%
AUM
$82.9B
AUM Growth
+$4.42B
(+5.6%)
Cap. Flow
-$9.54B
Cap. Flow
% of AUM
-11.51%
Top 10 Holdings %
Top 10 Hldgs %
19.76%
Holding
2,041
New
152
Increased
533
Reduced
967
Closed
217
Top Buys
| 1 |
XYZ
Block, Inc.
XYZ
|
+$280M |
| 2 |
Tesla
TSLA
|
+$269M |
| 3 |
FedEx
FDX
|
+$201M |
| 4 |
Marvell Technology
MRVL
|
+$176M |
| 5 |
GTM
ZoomInfo Technologies
GTM
|
+$172M |
Top Sells
| 1 |
CZR
Caesars Entertainment Corporation
CZR
|
+$462M |
| 2 |
Microsoft
MSFT
|
+$348M |
| 3 |
CrowdStrike
CRWD
|
+$290M |
| 4 |
CCI.PRA
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
|
+$219M |
| 5 |
Apple
AAPL
|
+$203M |
Sector Composition
| 1 | Technology | 30.92% |
| 2 | Consumer Discretionary | 11.17% |
| 3 | Healthcare | 10.85% |
| 4 | Financials | 9.38% |
| 5 | Communication Services | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Arcus Biosciences
RCUS
$1.25B
| $908K | ﹤0.01% |
53,005
-48,120
| -48% | -$824K |
|
|
BTEC
1327
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
| $905K | ﹤0.01% |
18,999
-1,426
| -7% | -$67.9K |
|
1328
Brunswick
BC
$4.23B
| $904K | ﹤0.01% |
+15,348
| New | +$904K |
|
1329
Essential Properties Realty Trust
EPRT
$5.88B
| $900K | ﹤0.01% |
49,111
-2,931
| -6% | -$53.7K |
|
1330
Inseego
INSG
$199M
| $898K | ﹤0.01% |
+8,700
| New | +$898K |
|
1331
DraftKings
DKNG
$22.7B
| $896K | ﹤0.01% |
+15,223
| New | +$896K |
|
1332
Brinker International
EAT
$6.88B
| $896K | ﹤0.01% |
20,968
-1,498
| -7% | -$64K |
|
1333
Unilever
UL
$154B
| $896K | ﹤0.01% |
14,520
+491
| +3% | +$30.3K |
|
1334
Kemper
KMPR
$3.32B
| $887K | ﹤0.01% |
13,269
-2,285
| -15% | -$153K |
|
|
MGLN
1335
DELISTED
Magellan Health Services, Inc.
MGLN
| $884K | ﹤0.01% |
+11,663
| New | +$884K |
|
1336
Zentalis Pharmaceuticals
ZNTL
$105M
| $881K | ﹤0.01% |
+26,955
| New | +$881K |
|
|
RETA
1337
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $880K | ﹤0.01% |
9,030
-21,753
| -71% | -$2.12M |
|
1338
GATX Corp
GATX
$6B
| $870K | ﹤0.01% |
13,647
+5,291
| +63% | +$337K |
|
1339
NCR Voyix
VYX
$1.73B
| $866K | ﹤0.01% |
63,764
+14,743
| +30% | +$200K |
|
|
JCAP
1340
DELISTED
Jernigan Capital, Inc.
JCAP
| $866K | ﹤0.01% |
+50,500
| New | +$866K |
|
|
SGI
1341
Somnigroup International Inc.
SGI
$17.9B
| $859K | ﹤0.01% |
38,504
+18,692
| +94% | +$417K |
|
1342
QuidelOrtho
QDEL
$1.88B
| $856K | ﹤0.01% |
3,901
-6,880
| -64% | -$1.51M |
|
1343
Seres Therapeutics
MCRB
$154M
| $855K | ﹤0.01% |
+1,510
| New | +$855K |
|
|
MODV
1344
DELISTED
ModivCare
MODV
| $855K | ﹤0.01% |
9,200
-1,382
| -13% | -$128K |
|
1345
SLM Corp
SLM
$6.01B
| $851K | ﹤0.01% |
105,146
+92,777
| +750% | +$751K |
|
1346
Rithm Capital
RITM
$6.63B
| $847K | ﹤0.01% |
106,523
-38,000
| -26% | -$302K |
|
1347
Flowers Foods
FLO
$3.02B
| $841K | ﹤0.01% |
34,584
-6,631
| -16% | -$161K |
|
1348
ASE Group
ASX
$24.6B
| $838K | ﹤0.01% |
205,339
+30,995
| +18% | +$126K |
|
1349
Kennametal
KMT
$1.59B
| $832K | ﹤0.01% |
+28,748
| New | +$832K |
|
1350
Evergy
EVRG
$16.5B
| $830K | ﹤0.01% |
16,339
+3,759
| +30% | +$191K |
|